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This is the authors’ response to peer-review reports for the
paper “Why We Are Losing the War Against COVID-19 on the
Data Front and How to Reverse the Situation”.
Round 1 Review
The authors of the manuscript [1] thank the reviewers [2-5] for
their comments. In addition to making changes in response, we
have also updated the paper in various places given the changing
nature of the pandemic and the response to it.
Reviewer A
General Comments
The What Can Be Done? section has been rewritten with much
more detail.
Specific Comments
1. Thank you for your suggestion. Details on procedures for
data collection and processing will be very dependent on the
characteristics of each health system and the data routinely
collected for clinical care, so it will be difficult for us to suggest
here a particular system. However, in point 2 of the What Can
Be Done? section, we have added some points that any health
system should consider when planning the data collection
strategy.
2. Thank you for the suggestion; we actually asked some expert
colleagues informally for their opinion on a possible data
structure, and we received different answers (more or less
overlapping in some variables). We realized that defining the
data set is a task that should be done by an expert panel
considering not only the disease but also the characteristics of
the health system that will collect the data and the cost/benefit
of collecting each piece of data. We have now elaborated on
this idea in point 1 in the What Can Be Done? section.
3. “Immediately used for data collection” is a relative term as
any platform would have to be adapted to the decided data
structure. There are many tools out there with different degrees
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of adaptability, but the point here is to use as much as possible
the existing health information systems in place to extract the
data and create feedback loops to the health care system, rather
than setting up separate platforms.
4. Automatic data processing is not a problem of software. Any
modern statistical software can be programmed to repeat data
processing of analytical routines. The key issue is to decide
what to analyze and with what statistical models. The statistical
experts will define the models needed to answer the questions




1. Thank you for the suggestion; we have tried to improve this,
including adding some more citations.
2. Thank you for highlighting these interesting points. We have
internally discussed the idea of who should be coordinating the
international effort to combine data and analysis and we largely
agree with it. However, we feel that exceeds the scope of our
original aim for this paper—to highlight the missing opportunity
of implementing learning health system within health care
systems and taking it to the next level of international
coordination of health learning systems.
About the funding, that will depend very much on the kind of
health systems and even the society where the health system is
embedded, and we cannot comment on each case separately.
For example, in the countries where the authors work and live,
the health systems are mainly publicly funded, and we would
expect the competent public authorities to make that funding
effort just as they did with the extra effort for medical care
during the pandemic. Other systems might have to find other
resources. In any case, one needs to consider this as an
investment because the earlier we learn to effectively manage
the pandemic, the more we can reduce costs in the long run.
3. We do not really know the answer to this certainly very
important question, but we believe it is complex enough to
require a separate piece of research. For the problem that we
are trying to address here, about implementing health learning
systems, we must assume that each system will try to find the
most up-to-date and “reliable” scientific information available
at the time. We understand that the most recent information
could be incomplete and possibly unreplicated so far. So, the
learning health system should be constantly revised and updated
as new solid information is made available. We have added a
new point 8 in the What Can Be Done? section discussing this
issue.
Anonymous [4]
1. Thank you for the comment; we certainly do not try to predict
how information on the pandemic will evolve in the future. We
rather try to denounce how the opportunity has been missed to
implement a useful, responsive health information system
embedded in the health care system.
2. Thank you for the comment. Because the paper is not a typical
research paper with an introduction, methods, results, discussion,
etc, we found it difficult to follow a similar structure in the
abstract. However, we have revised the abstract to clarify the
purpose of the research in its final paragraph.
3. Thank you for the comment. We do not have an Introduction
section as such, but we have split this into 2 sections, The
Problem and What Do We Need to Solve the Problem?, which
we believe address the purpose of this paper.
4. Because the paper is not a typical research paper, we do not
have an Introduction section as such.
5. Thank you for the references. They look very relevant for a
discussion on public policies to tackle the pandemic. We are
not sure how to fit them in our paper, which focuses on learning
health systems, but we will consider them in future works.
6. Thank you for the comment. Because the paper is not a typical
research paper, we found it difficult to follow a typical structure
in the Conclusion section. However, we have added some





1. Thank you for the suggestion. We actually asked some expert
colleagues informally for their opinion on a possible data
structure, and we received different answers (more or less
overlapping in some variables). We realized that defining the
data set is a task that should be done by an expert panel
considering not only the disease but also the characteristics of
the health system that will collect the data and the cost/benefit
of collecting each piece of data. We have now elaborated on
this idea in point 1 of the What Can Be Done? section.
2. Thanks for the comment. In the section What Is Being Done?,
we did include references to some initiatives that were taken to
collect and analyze COVID-19 clinical data. There are, of
course, many more, but it is not the aim of this paper to review
them. We included some points discussing the shortcomings of
many of these systems, mostly independent from actual health
care systems. We have now included references to some
initiatives at the national level (most notoriously one in the
United Kingdom) but note that we still fall short of the concept
of the learning health system that we propose.
3. Yes, we can see your point, although we regard electronic
medical record (EMR) vendors as service providers who do not
actually own the data or the right to exploit it. We believe this
to be the situation at least in Europe where the data mostly
“belong” to the institutions providing the health services (in the
sense that they are the “data controllers” under GDPR [General
Data Protection Regulation] regulations). We are assuming that
is up to these institutions to decide what data they collect,
process, analyze, and share, and we view EMR vendors just as
companies providing software support. Maybe in other countries
the situation is different. To discuss all these different situations
will make the paper too long and probably deviate from the
main message of implementing learning health systems
integrated with health care systems. Maybe one can consider
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EMR vendors as an element of the “health care system” in





1. Thank you for your comment. We acknowledge that more
references could have been provided. On the other hand, we
would not want to overload the reader with references for points
that are quite well known to the public, such as the situation of
the pandemic and the actions of many countries to tackle it, that
we mention in the first paragraph. Regarding point 7, this
proposition is of a speculative nature rather than affirmative.
We have not verified it with data; we have just derived it from
the logic that the more appealing a given resource is, the more
demanded it will be by the potential beneficiaries of its use and
the more likely that a bottleneck will be created if the access
points to that resource are kept at a constant capacity of delivery.
Certainly, these bottlenecks would be ameliorated if the capacity
to deliver that resource is improved to keep up with the demand,
and we have included this idea by adding the following sentence
“(unless more resources are put into place to deal with the
requests).”
2. In the third paragraph of The Problem, we mention some
limitations of the epidemiological data. Epidemiological data
are very valuable for monitoring the epidemic and deciding on
public health measures but are more limited for understanding
the risk factors for getting infected and for predicting the
prognosis of patients or their response to treatment.
Epidemiological data might provide the distribution of cases
by age groups, gender, ethnicity, etc, but they provide limited
information on the combinations of these risk factors. If we
want to combine the distribution of several risk factors (eg, sex,
age, ethnicity, socioeconomic status, previous comorbidities,
etc), it is unlikely that the epidemiological reports will provide
this. Another limitation is that continuous variables such as age,
BMI, blood pressure, and respiratory rate are categorized to
produce report tables, and the usefulness of the variable is
reduced. Also, epidemiological reports normally do not include
parameters collected in hospitals during the progression of the
disease that could be critical for creating prognostic models to
predict which patients would benefit more from what treatments.
We have included some sentences clarifying these limitations
in that third paragraph.
3. A critical point to solve a research question with a learning
health system is to find suitable cases. The learning health
system would check every new patient in the system to see if
they match the research question criteria to be included. A health
system implemented only at one center will answer the question
with enough certainty when enough patients have been recruited
at that center. Noncoordinated health systems implemented
separately at different centers will take as much time to get to
an answer, but if they were coordinated and share data pertaining
to new, valid patients, then they will be closer to answering the
question.
4. Our point is precisely that at the moment current practices
do not implement what we call a health system as defined in
our references 3 and 4. We have tried to illustrate in the section
The Problem the failure to answer the most pressing clinical
questions even after having millions of cases, hundreds of
thousands of deaths, and vast amounts of epidemiological data.
This failure is in itself a manifestation of the lack of a health
learning system (we are not learning fast enough). In section
What Can Be Done?, we provide some examples of the
innovative initiatives taken to tackle this problem, but we also
argue why they fall short of being a health learning system. In
this section, we propose the characteristics of what we would
consider a learning health system, which can be summarized
as:
1. An organizational architecture that facilitates the formation
of communities of patients, families, front-line clinicians,
researchers, and health system leaders who collaborate to
produce and use big data;
2. Large electronic health and health care data sets (big data);
3. Quality improvement for each patient at the point of care
brought about by the integration of relevant new knowledge
generated through research;
4. Observational research and clinical trials done in routine
clinical care settings.
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